Ruifeng Yang

1.1k total citations
8 papers, 608 citations indexed

About

Ruifeng Yang is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Ruifeng Yang has authored 8 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Molecular Biology and 2 papers in Virology. Recurrent topics in Ruifeng Yang's work include SARS-CoV-2 and COVID-19 Research (2 papers), HIV Research and Treatment (2 papers) and Protein Structure and Dynamics (2 papers). Ruifeng Yang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), HIV Research and Treatment (2 papers) and Protein Structure and Dynamics (2 papers). Ruifeng Yang collaborates with scholars based in United States, China and Hong Kong. Ruifeng Yang's co-authors include Christopher Aiken, Peijun Zhang, Jason Concel, Jin-Woo Ahn, Xiaowei Xu, Xin Meng, Angela M. Gronenborn, In‐Ja L. Byeon, Jiong Shi and Gongpu Zhao and has published in prestigious journals such as Cell, Nature Communications and Journal of Molecular Biology.

In The Last Decade

Ruifeng Yang

8 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruifeng Yang United States 7 237 197 186 125 105 8 608
E. Major United States 9 118 0.5× 112 0.6× 37 0.2× 377 3.0× 37 0.4× 10 604
L.J. Stroh Germany 14 194 0.8× 108 0.5× 21 0.1× 338 2.7× 81 0.8× 20 668
Eszter Csoma Hungary 13 104 0.4× 80 0.4× 28 0.2× 136 1.1× 26 0.2× 33 397
Gregory A. Sowd United States 15 594 2.5× 332 1.7× 494 2.7× 80 0.6× 57 0.5× 21 957
Kathryn S. Campbell United States 6 317 1.3× 34 0.2× 22 0.1× 341 2.7× 64 0.6× 10 612
Jason Nomburg United States 9 125 0.5× 52 0.3× 14 0.1× 139 1.1× 38 0.4× 12 361
Dorian McIlroy France 19 405 1.7× 124 0.6× 327 1.8× 175 1.4× 13 0.1× 32 1.3k
Takamasa Takeuchi Japan 16 388 1.6× 72 0.4× 27 0.1× 144 1.2× 16 0.2× 54 783
Adam L. Moyer United States 7 145 0.6× 59 0.3× 13 0.1× 393 3.1× 51 0.5× 7 641
Kathryn H. Richards United Kingdom 8 90 0.4× 47 0.2× 40 0.2× 103 0.8× 7 0.1× 10 354

Countries citing papers authored by Ruifeng Yang

Since Specialization
Citations

This map shows the geographic impact of Ruifeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruifeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruifeng Yang more than expected).

Fields of papers citing papers by Ruifeng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruifeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruifeng Yang. The network helps show where Ruifeng Yang may publish in the future.

Co-authorship network of co-authors of Ruifeng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruifeng Yang. A scholar is included among the top collaborators of Ruifeng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruifeng Yang. Ruifeng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Zhang, Haiying, Ying Ji, Cong Xu, et al.. (2022). Inactivated Vaccines Against SARS-CoV-2: Neutralizing Antibody Titers in Vaccine Recipients. Frontiers in Microbiology. 13. 816778–816778. 15 indexed citations
2.
Wang, Zilong, et al.. (2022). An Ideal Hallmark Closest to Complete Cure of Chronic Hepatitis B Patients: High-sensitivity Quantitative HBsAg Loss. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 8 indexed citations
3.
Yang, Ruifeng, et al.. (2021). Auricular acupuncture for shoulder pain. Medicine. 100(17). e25666–e25666. 6 indexed citations
4.
Liu, Wei, Ruifeng Yang, Aimee Payne, et al.. (2016). Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection. Cell Host & Microbe. 19(6). 775–787. 138 indexed citations
5.
Yang, Ruifeng, Ying Zheng, Michelle Burrows, et al.. (2014). Generation of folliculogenic human epithelial stem cells from induced pluripotent stem cells. Nature Communications. 5(1). 3071–3071. 86 indexed citations
6.
Du, Shoucheng, Laurie Betts, Ruifeng Yang, et al.. (2010). Structure of the HIV-1 Full-Length Capsid Protein in a Conformationally Trapped Unassembled State Induced by Small-Molecule Binding. Journal of Molecular Biology. 406(3). 371–386. 50 indexed citations
7.
Byeon, In‐Ja L., Xin Meng, Jinwon Jung, et al.. (2009). Structural Convergence between Cryo-EM and NMR Reveals Intersubunit Interactions Critical for HIV-1 Capsid Function. Cell. 139(4). 780–790. 218 indexed citations
8.
Wang, Yuedan, Guobing Xu, Xuewen Pang, et al.. (2004). T-Cell Epitopes in Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Protein Elicit a Specific T-Cell Immune Response in Patients Who Recover from SARS. Journal of Virology. 78(11). 5612–5618. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026